Abstract
RhD negative pregnant women who carry an RhD positive fetus are at risk of immunization against the D antigen, which may result in hemolytic disease of the fetus and the newborn. Predicting the fetal RhD status by noninvasive antenatal screening for the fetal RhD gene (RHD) can guide targeted use of antenatal anti-D prophylaxis.
Cell-free fetal DNA is extracted from maternal plasma from RhD negative pregnant women at a gestational age of 25 weeks. A real-time PCR-based detection of two RHD exons enables reliable prediction of the fetal RhD status to determine the administration of antenatal prophylaxis, as well as postnatal prophylaxis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Urbaniak SJ, Greiss MA (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev 14(1):44–61. https://doi.org/10.1054/blre.1999.0123
Urbaniak SJ (1998) The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol 105(Suppl 18):11–18
Clausen FB (2014) Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat Diagn 34(5):409–415. https://doi.org/10.1002/pd.4326
Clausen FB, Damkjaer MB, Dziegiel MH (2014) Noninvasive fetal RhD genotyping. Transfus Apher Sci 50(2):154–162. https://doi.org/10.1016/j.transci.2014.02.008
Clausen FB, Christiansen M, Steffensen R, Jorgensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck K, Sprogoe U, Homburg KM, Grunnet N, Dziegiel MH (2012) Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 52(4):752–758. https://doi.org/10.1111/j.1537-2995.2011.03362.x
Clausen FB, Steffensen R, Christiansen M, Rudby M, Jakobsen MA, Jakobsen TR, Krog GR, Madsen RD, Nielsen KR, Rieneck K, Sprogoe U, Homburg KM, Baech J, Dziegiel MH, Grunnet N (2014) Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. Prenat Diagn 34(10):1000–1005. https://doi.org/10.1002/pd.4419
Daniels G (2009) The molecular genetics of blood group polymorphism. Hum Genet 126(6):729–742. https://doi.org/10.1007/s00439-009-0738-2
Daniels G (2013) Variants of RhD--current testing and clinical consequences. Br J Haematol 161(4):461–470. https://doi.org/10.1111/bjh.12275
Fagredaktion S, Poulsen A (eds) (2009) Anbefalinger for Svangreomsorgen [recommendations for pregnancy and birth], 1st edn. Danish National Board of Health, Copenhagen ISBN:978-87-7676-906-2
Clausen FB, Krog GR, Rieneck K, Rasmark EE, Dziegiel MH (2011) Evaluation of two real-time multiplex PCR screening assays detecting fetal RHD in plasma from RhD negative women to ascertain the requirement for antenatal RhD prophylaxis. Fetal Diagn Ther 29(2):155–163. https://doi.org/10.1159/000321347
Clausen FB, Jakobsen TR, Rieneck K, Krog GR, Nielsen LK, Tabor A, Dziegiel MH (2013) Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD. PLoS One 8(10):e76990. https://doi.org/10.1371/journal.pone.0076990
Krog GR, Clausen FB, Dziegiel MH (2007) Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion 47(4):715–722. https://doi.org/10.1111/j.1537-2995.2007.01175.x
Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Legler TJ (2011) Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. Prenat Diagn 31(13):1300–1304. https://doi.org/10.1002/pd.2889
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Clausen, F.B., Rieneck, K., Krog, G.R., Bundgaard, B.S., Dziegiel, M.H. (2019). Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis. In: Levy, B. (eds) Prenatal Diagnosis. Methods in Molecular Biology, vol 1885. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8889-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8889-1_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8887-7
Online ISBN: 978-1-4939-8889-1
eBook Packages: Springer Protocols